Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients

Evaluation of the Efficacy and Safety of Changes in Antiretroviral Regimens for HIV-infected Patients

Purpose. Antiretroviral therapy is now available for HIV-infected patients, and so-called highly active antiretroviral therapy (HAART) now makes it possible to strongly suppress viral proliferation and restore immunity. However, the development of new drugs and regimens for HAART is still in progre...

Full description

Bibliographic Details
Main Authors:	Hiroyuki Tanaka, Tatsuhiko Wada, Yoko Takayama, Keisuke Matsumoto, Koichiro Atsuda, Mitsutoshi Satoh
Format:	Article
Language:	English
Published:	Canadian Society for Pharmaceutical Sciences 2014-07-01
Series:	Journal of Pharmacy & Pharmaceutical Sciences
Online Access:	https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/21517

Similar Items

THE RESULTS OF THE EFFICACY AND SAFETY OF THE NEW RUSSIAN DRUG 6НР IN THE ANTIRETROVIRAL THERAPY REGIMENS OF HIV-INFECTED PATIENTS
by: A. V. Kravchenko, et al.
Published: (2019-03-01)

Evaluation of Renal Adverse Effects of Combination Anti-retroviral Therapy including Tenofovir in HIV-infected Patients
by: Hiroyuki Tanaka, et al.
Published: (2013-05-01)

Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
by: Stephan C, et al.
Published: (2010-09-01)

Cost-Efficacy of Antiretroviral Regimens Recommended in Treatment-Naive HIV-Infected Adults. A Single Center Experience
by: Raluca Jipa, et al.
Published: (2021-05-01)

Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings.
by: Thomas B Campbell, et al.
Published: (2012-01-01)

Characteristics of HIV antiretroviral regimen and treatment adherence
by: Vera Lúcia da Silveira, et al.

Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults
by: Edwin DeJesus, et al.
Published: (2019-05-01)

Investigation of the Clinical Efficacy and Dosage of Intravenous Ciprofloxacin in Patients with Respiratory Infection
by: Mitsutoshi Satoh
Published: (2009-01-01)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
by: Nicola Gianotti, et al.
Published: (2017-01-01)

Efficacy and safety of darunavir and etravirine in an antiretroviral multi-experienced youth with vertically HIV-1 infection
by: Rosso R, et al.
Published: (2009-03-01)

Towards an ideal antiretroviral regimen for the global HIV epidemic
by: Beatriz Grinsztejn, et al.
Published: (2017-07-01)

Persistence to single-tablet regimen versus less-drug regimen in treatment experienced HIV-infected patients on antiretroviral therapy
by: Rocio Jiménez-Galán, et al.
Published: (2016-07-01)

Response to a Protease-Inhibitor (Ritonavir)-Containing Combination Antiretroviral Regimen in HIV-Infected Children
by: Upton D Allen, et al.
Published: (2003-01-01)

Prevalence of Hepatitis B in HIV infected persons: choice of antiretroviral therapy regimen and implications for screening
by: Reidy, Derval
Published: (2015)

Efficacy and safety of a once-daily single-tablet regimen of tenofovir, lamivudine, and efavirenz assessed at 144 weeks among antiretroviral-naïve and experienced HIV-1-infected Thai adults
by: Anchalee Avihingsanon, et al.
Published: (2017-08-01)

Persistent intracellular HIV transcription in individuals on stable antiretroviral regimens
by: Dimitrios Pilalas, et al.
Published: (2018-05-01)

Effectiveness of four antiretroviral regimens for treating people living with HIV.
by: Aracele Tenório de Almeida E Cavalcanti, et al.
Published: (2020-01-01)

Modern antiretroviral regimens
by: A. V. Kravchenko
Published: (2016-12-01)

Virological and immunological efficacy of metabolically favorable antiretroviral therapy regimens in HIV patients who had no previous treatment
by: E. I. Veselova, et al.
Published: (2020-06-01)

Renal safety of tenofovir containing antiretroviral regimen in a Singapore cohort
by: Chua Arlene C, et al.
Published: (2012-06-01)

Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study.
by: Ume L Abbas, et al.
Published: (2019-01-01)

Immunologic Response of HIV-Infected Children to Different Regimens of Antiretroviral Therapy: A Retrospective Observational Study
by: Teshale Ayele Mega, et al.
Published: (2020-01-01)

Antiretroviral therapy in HIV-infected patients: a proposal to assess the economic value of the single-tablet regimen
by: Colombo GL, et al.
Published: (2013-02-01)

Raltegravir is the first HIV integrase inhibitor as part of antiretroviral treatment regimens
by: Aleksey Viktorovich Kravchenko, et al.
Published: (2010-11-01)

Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study
by: Sanjeev Sinha, et al.
Published: (2017-12-01)

Differential efficacy of antiretroviral drugs in HIV-1 infected human microglia
by: E.L. Asahchop, et al.
Published: (2015-12-01)

Single Tablet Regimen Usage and Efficacy in the Treatment of HIV Infection in Australia
by: B. Armstrong, et al.
Published: (2015-01-01)

Antiretroviral Regimens in HIV-Infected Adults Receiving Medical Care in the United States: Medical Monitoring Project, 2009
by: Tie, Yunfeng
Published: (2013)

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis.
by: Mario Cruciani, et al.
Published: (2019-01-01)

The Efficacy and Safety of Sofosbuvir Containing Regimen in the Treatment of Hcv Infection in Patients with Haemoglobinopathy
by: Nawfal R Hussein
Published: (2017-01-01)

Dolutegravir: Virologic response and tolerability of initial antiretroviral regimens for adults living with HIV.
by: Analú Correa, et al.
Published: (2020-01-01)

Treatment outcome of different antiretroviral drug regimens in HIV-positive pregnant women
by: Nidhi Chauhan, et al.
Published: (2021-01-01)

Efficacy and safety of abacavir/lamivudine plus rilpivirine as a first-line regimen in treatment-naïve HIV-1 infected adults
by: Sharlene Ho, et al.
Published: (2020-05-01)

Incidence and Predictors of Initial Antiretroviral Therapy Regimen Change Among HIV-Infected Adults Receiving Antiretroviral Therapy at Arba Minch General Hospital, Southern Ethiopia
by: Gebremichael MA, et al.
Published: (2020-08-01)

Nevirapine-based regimens in HIV-infected antiretroviral-naive patients: systematic review and meta-analysis of randomized controlled trials.
by: Paweł Kawalec, et al.
Published: (2013-01-01)

The influence of genetic factors on the effectiveness, safety and tolerability of antiretroviral therapy in patients with hiv infection
by: V. G. Kanestri, et al.
Published: (2021-03-01)

Thalidomide is Associated With Increased T Cell Activation and Inflammation in Antiretroviral-naive HIV-infected Individuals in a Randomised Clinical Trial of Efficacy and Safety
by: Tânia R.C. Vergara, et al.
Published: (2017-09-01)

Comparison of Treatment Outcomes among Second-Line Antiretroviral Regimens in HIV/AIDS Patient
by: Winda Dwi Puspitasari, et al.
Published: (2018-10-01)

Dolutegravir-Based Antiretroviral Regimens for HIV Liver Transplant Patients in Real-Life Settings
by: Dario Cattaneo, et al.
Published: (2020-03-01)

Simplified Assessment of Antiretroviral Adherence and Prediction of Virological Efficacy in HIV-Infected Patients in Cambodia
by: Olivier Segeral, et al.
Published: (2010-01-01)